Validation of a Metastatic Assay using biopsies to improve risk stratification in patients with prostate cancer treated with radical radiation therapy

BACKGROUND: Radiotherapy is an effective treatment of intermediate/high-risk locally advanced prostate cancer, however, >30% of patients relapse within 5 years. Clinicopathological parameters currently fail to identify patients prone to systemic relapse and those whom treatment intensification ma...

Descripción completa

Detalles Bibliográficos
Autores principales: Jain, S, Lyons, C A, Walker, S M, McQuaid, S, Hynes, S O, Mitchell, D M, Pang, B, Logan, G E, McCavigan, A M, O’Rourke, D, McArt, D G, McDade, S S, Mills, I G, Prise, K M, Knight, L A, Steele, C J, Medlow, P W, Berge, V, Katz, B, Loblaw, D A, Harkin, D P, James, J A, O’Sullivan, J M, Kennedy, R D, Waugh, D J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5834121/
https://www.ncbi.nlm.nih.gov/pubmed/29045551
http://dx.doi.org/10.1093/annonc/mdx637

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5834121/
https://www.ncbi.nlm.nih.gov/pubmed/29045551
http://dx.doi.org/10.1093/annonc/mdx637

Ejemplares similares